Assessment of cardiovascular risk

Current Hypertension Reports

Volumn 12, Issue 5, 2010, Pages 384-393

  Cooney, Marie Therese ^a   Cooney, Helen C ^a   Dudina, Alexandra ^a   Graham, Ian M ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Cardiovascular disease; Guidelines; Primary prevention; Risk; Risk assessment; Risk estimation; SCORE; Total cardiovascular risk

Indexed keywords

CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; INTERMETHOD COMPARISON; PATIENT ASSESSMENT; PATIENT IDENTIFICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

AGE FACTORS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COMORBIDITY; GUIDELINES AS TOPIC; HEART RATE; HUMANS; RISK ASSESSMENT; SEX FACTORS; SMOKING;

EID: 77958510276     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0143-1     Document Type: Review

References (52)

1. The Global Burden of Disease: 2004 Update. World Health Organization, Geneva, Switzerland, 2008.
2. MT Cooney A Dudina P Whincup, et al. 2009 Reevaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies Eur J Cardiovasc Prev Rehabil 16 5 541 549 10.1097/HJR.0b013e32832b38a1 19773660
3. G Rose 1985 Sick individuals and sick populations Int J Epidemiol 14 32 38 1:STN:280:DyaL2M7otFynsA%3D%3D 10.1093/ije/14.1.32 3872850
4. G De Backer E Ambrosioni K Borch-Johnsen, et al. 2003 European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) Eur J Cardiovasc Prev Rehabil 10 4 S1 S10 10.1097/00149831- 200308000-00004 14555889
5. I Graham D Atar K Borch-Johnsen, et al. 2007 European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 Suppl 2 S1 S113 10.1097/01.hjr.0000277983.23934.c9 17726407 (Pubitemid 47339826)
6. O Hanon G Franconi JJ Mourad, et al. 2000 The estimation of cardiovascular risk in hypertensive patients is not modified by management of the hypertension] [in French Arch Mal Coeur Vaiss 93 943 947 1:STN:280:DC%2BD3cvkt1yhsg%3D%3D 10989734
7. J Genest R McPherson J Frohlich, et al. 2009 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations Can J Cardiol 25 567 579 1:CAS:528:DC%2BD1MXhtlynsLvF 19812802
8. RB D'Agostino Sr RS Vasan MJ Pencina, et al. 2008 General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 743 753 10.1161/CIRCULATIONAHA.107.699579 18212285 (Pubitemid 351640675)
9. RM Conroy K Pyorala AP Fitzgerald, et al. 2003 Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 987 1003 1:STN:280:DC%2BD3s3mtFGnuw%3D%3D 10.1016/S0195-668X(03)00114-3 12788299 (Pubitemid 36712275)
10. M Woodward P Brindle H Tunstall-Pedoe 2007 Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) Heart 93 172 176 10.1136/hrt.2006.108167 17090561 (Pubitemid 46180289)
11. J Hippisley-Cox C Coupland Y Vinogradova, et al. 2008 Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ 336 1475 1482 10.1136/bmj.39609.449676.25 18573856 (Pubitemid 351977019)
12. G Assmann P Cullen H Schulte 2002 Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study Circulation 105 310 315 10.1161/hc0302.102575 11804985 (Pubitemid 34106178)
13. H Ulmer B Kollerits C Kelleher, et al. 2005 Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women Eur J Cardiovasc Prev Rehabil 12 433 441 10.1097/01.hjr.0000174791.47059.80 16210929 (Pubitemid 44966787)
14. PM Ridker JE Buring N Rifai NR Cook 2007 Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 611 619 1:CAS:528:DC%2BD2sXhslCqtLk%3D 10.1001/jama.297.6.611 17299196
15. PM Ridker NP Paynter N Rifai, et al. 2008 C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2243 2251 1:CAS:528:DC%2BD1cXhtlyks7bE 10.1161/CIRCULATIONAHA.108.814251 18997194
16. P Brindle A Beswick T Fahey S Ebrahim 2006 Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review Heart 92 1752 1759 1:STN:280:DC%2BD28nmvFSrtA%3D%3D 10.1136/hrt.2006. 087932 16621883 (Pubitemid 44851316)
17. J Hippisley-Cox C Coupland Y Vinogradova, et al. 2007 Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study BMJ 335 136 10.1136/bmj.39261.471806.55 17615182 (Pubitemid 47172233)
18. M May DA Lawlor P Brindle, et al. 2006 Cardiovascular disease risk assessment in older women: Can we improve on Framingham? British Women's Heart and Health prospective cohort study Heart 92 1396 1401 1:STN:280: DC%2BD28rkvVWhtA%3D%3D 10.1136/hrt.2005.085381 16547204 (Pubitemid 44578825)
19. JP Empana P Ducimetiere D Arveiler, et al. 2003 Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study Eur Heart J 24 1903 1911 1:STN:280: DC%2BD3srgvFWitg%3D%3D 10.1016/j.ehj.2003.09.002 14585248 (Pubitemid 37322699)
20. T Scheltens WM Verschuren HC Boshuizen, et al. 2008 Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age Eur J Cardiovasc Prev Rehabil 15 562 566 10.1097/HJR.0b013e3283063a65 18756178
21. F Barzi A Patel D Gu, et al. 2007 Cardiovascular risk prediction tools for populations in Asia J Epidemiol Community Health 61 115 121 1:STN:280:DC%2BD2s%2FjsFWitQ%3D%3D 10.1136/jech.2005.044842 17234869 (Pubitemid 46174217)
22. McGorrian C, Leong T, D'Agostino R, Graham I: Risk estimation systems in clinical use: SCORE, Heart Score and the Framingham system. In Therapeutic Strategies in Cardiovascular Risk. Edited by D'Agostino R, Graham I. Oxford, UK: Clinical Publishing; 2008.
23. PW Wilson RB D'Agostino D Levy, et al. 1998 Prediction of coronary heart disease using risk factor categories Circulation 97 1837 1847 1:STN:280:DyaK1c3msVOjsA%3D%3D 9603539
24. KM Anderson PM Odell PW Wilson WB Kannel 1991 Cardiovascular disease risk profiles Am Heart J 121 293 298 1:STN:280:DyaK3M%2FovF2qtg%3D%3D 10.1016/0002-8703(91)90861-B 1985385
25. National Cholesterol Education Program (NCEP) Expert Panel on Detection 2002 Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143 3421
26. J Marrugat R D'Agostino L Sullivan, et al. 2003 An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas J Epidemiol Community Health 57 634 638 1:STN:280:DC%2BD3szntFWjtw%3D%3D 10.1136/jech.57.8.634 12883073 (Pubitemid 36930293)
27. J Liu Y Hong RB D'Agostino Sr, et al. 2004 Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study JAMA 291 2591 2599 1:CAS:528: DC%2BD2cXkslWnsro%3D 10.1001/jama.291.21.2591 15173150 (Pubitemid 38702777)
28. RB D'Agostino Sr 2001 Grundy S, Sullivan LM, Wilson P: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 286 180 187 10.1001/jama.286.2.180 11448281
29. New Zealand Guidelines Group: New Zealand Cardiovascular Guidelines Handbook: A Summary Resource for Primary Care Practitioners, edn 2. Wellington: New Zealand Guidelines Group; 2009.
30. British Cardiac Society, British Hypertension Society, Diabetes UK, et al.: JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005, 91(Suppl 5):v1-v52.
31. CG Isles LD Ritchie P Murchie J Norrie 2000 Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods BMJ 320 690 691 1:STN:280:DC%2BD3c7nslGrsg%3D%3D 10.1136/bmj.320.7236. 690 10710579
32. P Marques-Vidal N Rodondi M Bochud, et al. 2008 Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland Eur J Cardiovasc Prev Rehabil 15 402 408 10.1097/HJR.0b013e3282fb040f 18677163
33. DB Panagiotakos AP Fitzgerald C Pitsavos, et al. 2007 Statistical modelling of 10-year fatal cardiovascular disease risk in Greece: the HellenicSCORE (a calibration of the ESC SCORE project) Hellenic J Cardiol 48 55 63 17489342
34. S Sans AP Fitzgerald D Royo, et al. 2007 Calibrating the SCORE cardiovascular risk chart for use in Spain] [in Spanish Rev Esp Cardiol 60 476 485 17535758
35. HW Hense E Koesters J Wellmann, et al. 2008 Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany Eur J Cardiovasc Prev Rehabil 15 409 415 10.1097/HJR.0b013e3282feec66 18677164
36. Prevention of Cardiovascular Disease: Guidelines for assessment and management of cardiovascular risk. Geneva, World Health Organization, 2007.
37. W de Ruijter RG Westendorp WJ Assendelft, et al. 2009 Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ 338 a3083 10.1136/bmj.a3083 19131384
38. B Zethelius L Berglund J Sundstrom, et al. 2008 Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2107 2116 1:CAS:528:DC%2BD1cXlvFCrsrw%3D 10.1056/NEJMoa0707064 18480203 (Pubitemid 351679597)
39. S Stork RA Feelders AW van den Beld, et al. 2006 Prediction of mortality risk in the elderly Am J Med 119 519 525 10.1016/j.amjmed.2005.10.062 16750966 (Pubitemid 43795183)
40. S Anand S Islam A Rosengren, et al. 2008 Risk factors for myocardial infarction in women and men: insights from the INTERHEART study Eur Heart J 29 932 940 10.1093/eurheartj/ehn018 18334475 (Pubitemid 351499478)
41. SA Grover I Lowensteyn L Joseph, et al. 2007 Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial Arch Intern Med 167 2296 2303 1:CAS:528:DC%2BD2sXhsVKgt7rM 10.1001/archinte.167.21.2296 18039987 (Pubitemid 350179523)
42. MJ Pencina RB D'Agostino Sr 2008 D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 157 172 10.1002/sim.2929 17569110 (Pubitemid 351193639)
43. NR Cook 2008 Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve Clin Chem 54 17 23 1:CAS:528:DC%2BD1cXmtFemuw%3D%3D 10.1373/clinchem.2007.096529 18024533 (Pubitemid 351182592)
44. NR Cook JE Buring PM Ridker 2006 The effect of including C-reactive protein in cardiovascular risk prediction models for women Ann Intern Med 145 21 29 1:CAS:528:DC%2BD28XnslKhtL4%3D 16818925
45. P Wilson M Pencina P Jacques, et al. 2008 C-Reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes 1 92 97 10.1161/CIRCOUTCOMES.108.831198 20031795
46. SM Grundy JI Cleeman CN Merz, et al. 2004 Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Arterioscler Thromb Vasc Biol 24 e149 e161 1:CAS:528: DC%2BD2cXmtValt7c%3D 10.1161/01.ATV.0000133317.49796.0E 15297292
47. Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. A national clinical guideline. 2007.
48. National Institute for Health and Clinical Excellence: Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guideline 67, 2008. Available at http://www.nice.org.uk/nicemedia/live/ 11982/40689/40689.pdf. Accessed 14 July 2010.
49. MT Cooney AL Dudina IM Graham 2009 Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians J Am Coll Cardiol 54 1209 1227 10.1016/j.jacc.2009.07.020 19778661
50. TJ Wang P Gona MG Larson, et al. 2006 Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2631 2639 1:CAS:528:DC%2BD28XhtlGhtLvJ 10.1056/NEJMoa055373 17182988 (Pubitemid 44969122)
51. M Cooney A Dudina DD Bacquer, et al. 2009 How much does HDL cholesterol add to risk estimation? - A report from the SCORE investigators Eur J Cardiovasc Prev Rehabil 16 304 314 10.1097/HJR.0b013e3283213140 19609139
52. Cooney M, Vartiainen E, Laatikainen T, et al.: Simplifying Risk Estimation using Resting Heart Rate. Eur Heart J 2010 (in press).